← All News

Paracetamol Syrup Production Expanded for Pediatric Care

ETHRA expands paracetamol oral suspension manufacturing to meet growing pediatric demand, producing child-safe formulations at its Addis Ababa liquid dosage facility.

ETHRA Pharmaceuticals has expanded production of paracetamol oral suspension (syrup) to support pediatric fever and pain management across Ethiopian healthcare facilities.

Child-Safe Formulations

Our liquid dosage unit produces palatable, accurately dosed suspensions suitable for children, with batch records and stability data available for regulatory review.

Liquid Dosage Expertise

ETHRA’s liquid manufacturing suite also supports antibiotics, cough preparations, and other oral solutions — all produced under GMP conditions.

Request Specifications

Clinicians and procurement teams can request product monographs and supply terms through our contact page.

Stay Connected with ETHRA

Partnership inquiries, product specifications, and general information — our team is ready to help.

Contact Us